Morepen Laboratories Limited (NSE:MOREPENLAB)
42.97
-0.01 (-0.02%)
May 22, 2026, 3:29 PM IST
Morepen Laboratories Revenue
Morepen Laboratories had revenue of 4.84B INR in the quarter ending December 31, 2025, with 5.68% growth. This brings the company's revenue in the last twelve months to 17.87B, up 0.14% year-over-year. In the fiscal year ending March 31, 2025, Morepen Laboratories had annual revenue of 18.12B with 7.17% growth.
Revenue (ttm)
17.87B
Revenue Growth
+0.14%
P/S Ratio
1.32
Revenue / Employee
9.85M
Employees
1,814
Market Cap
23.51B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 18.12B | 1.21B | 7.17% |
| Mar 31, 2024 | 16.90B | 2.68B | 18.88% |
| Mar 31, 2023 | 14.22B | -1.34B | -8.60% |
| Mar 31, 2022 | 15.56B | 3.58B | 29.87% |
| Mar 31, 2021 | 11.98B | 3.40B | 39.57% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Indoco Remedies | 18.45B |
| Aarti Pharmalabs | 18.01B |
| Innova Captab | 16.30B |
| Solara Active Pharma Sciences | 13.75B |
| Windlas Biotech | 9.22B |
| Orchid Pharma | 8.11B |
| RPG Life Sciences | 7.08B |
| Ind-Swift Laboratories | 5.94B |
Morepen Laboratories News
- 4 days ago - Morepen Laboratories appoints Vipul Kumar Srivastava as Company Secretary - Business Upturn
- 4 weeks ago - Morepen Laboratories secures Rs 30 crore term loan from Shinhan Bank - Business Upturn
- 5 weeks ago - Morepen Labs gets US FDA clearance with 0 observations for Himachal unit, 4th straight nod with 0 observations - Business Upturn
- 2 months ago - Morepen Laboratories repays Rs 99 crore credit facility to Kotak Mahindra Bank - Business Upturn
- 2 months ago - Pharma sector stocks down today, March 2: Morepen Lab falls 3.24%, Ajanta Pharma drops 2.32%, Natco Pharma down 2.26% - Business Upturn
- 3 months ago - Morepen Laboratories shares surge nearly 15% today after Rs 825 crore global CDMO deal, up 30% in two days - Business Upturn
- 3 months ago - Pharma sector stocks today, Feb 23: Morepen Labs up 13.92%, Cohance Lifesciences jumps 4.37%, EMCURE Pharma down 3% - Business Upturn
- 3 months ago - Morepen Laboratories shares jump nearly 10% after Rs 825 crore global CDMO deal - Business Upturn